QuVa Pharma Revenue and Competitors
Estimated Revenue & Valuation
- QuVa Pharma's estimated annual revenue is currently $264M per year.
- QuVa Pharma received $41.0M in venture funding in July 2018.
- QuVa Pharma's estimated revenue per employee is $321,600
- QuVa Pharma's total funding is $356M.
Employee Data
- QuVa Pharma has 821 Employees.
- QuVa Pharma grew their employee count by 1% last year.
QuVa Pharma's People
| Name | Title | Email/Phone |
|---|---|---|
1 | Co-founder & CDO | Reveal Email/Phone |
2 | co-founder & CEO | Reveal Email/Phone |
3 | VP, Clinical Services | Reveal Email/Phone |
4 | VP, Technical Operations | Reveal Email/Phone |
5 | VP, Strategic Projects | Reveal Email/Phone |
6 | VP, Technical Operations | Reveal Email/Phone |
7 | VP Engineering & Facilities | Reveal Email/Phone |
8 | VP Manufacturing Operations | Reveal Email/Phone |
9 | Senior Director, IT Infrastructure and Security | Reveal Email/Phone |
10 | Chief Commercial Officer (CCO) | Reveal Email/Phone |
QuVa Pharma Competitors & AlternativesAdd Company
| Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
|---|---|---|---|---|---|
#1 | $107.3M | 534 | 9% | N/A | N/A |
#2 | $97.9M | 252 | -7% | N/A | N/A |
What Is QuVa Pharma?
QuVa Pharma is a nationally recognized company emerging as the leading industry 503B platform and partner of choice for compliance-oriented healthcare facilities looking to ensure a quality, safe and consistent supply of medications. The Company offers a broad portfolio of products across Pain Management, Anti-infective, OR Syringes, Labor and Delivery therapeutic areas amongst others, all of which are released only once sterility and potency testing is successfully complete, and with validation supporting appropriate BUD. The company is committed to having a patient-first orientation, as well as a robust product portfolio, leading safety standards, and collaborative, partnership-oriented customer service.
keywords:Biotechnology,Healthcare,Pharmaceuticals
$356M
Total Funding
821
Number of Employees
$264M
Revenue (est)
1%
Employee Growth %
N/A
Valuation
N/A
Accelerator
QuVa Pharma News
On April 28, 2020, QuVa Pharma Inc., a U.S. based intensifying drug ... market include Atlas Pharmaceuticals, Avella Specialty Pharmacy,...
SUGAR LAND, Texas, May 6, 2021 /PRNewswire/ -- QuVa Pharma, Inc.("QuVa Pharma"), the leading national 503B outsourcing services company providing hospitals with essential medications in ready-to-administer injectable formats, today announced its latest financing, a $275 million senior debt fac ...
SUGAR LAND, Texas, Oct. 28, 2020 /PRNewswire/ -- QuVa Pharma, Inc. announces it has expanded its partnership with Kit Check to support its increasing portfolio of products that include embedded RFID tags. The embedded RFID tags allow hospital pharmacists to add batches of medications to invent ...
SUGAR LAND, Texas, Sept. 26, 2018 /PRNewswire/ -- QuVa Pharma, Inc. today announced it has commenced manufacturing in newly ...
QuVa Pharma, a Sugar Land, Texas-based provider of compounded sterile products, raised additional debt funding of up to $41m. The new term loan is funded jointly by Silicon Valley Bank and Oxford Finance LLC. This additional capital infusion, which brings total capital invested to over $200 mil ...
Other Companies in Sugar Land
| Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
|---|---|---|---|---|
#1 | $307.3M | 896 | 4% | N/A |
#2 | $410M | 901 | 6% | N/A |
#3 | $6250M | 910 | 1% | $11M |
#4 | $323.1M | 942 | -2% | N/A |
#5 | $410.5M | 1086 | 8% | N/A |
QuVa Pharma Funding
| Date | Amount | Round | Lead Investors | Reference |
|---|---|---|---|---|
| 2018-02-01 | $15.0M | Undisclosed | Bain Capital | Article |
| 2018-07-25 | $41.0M | Undisclosed | Silicon Valley Bank | Article |